Conferences - Results from #8020

EAU 2017: 4th ESO Prostate Cancer Observatory: The Radiation Oncologist’s Perspective March 24, 2017

EAU 2017: 4th ESO Prostate Cancer Observatory: The Medical Oncologist’s Perspective March 24, 2017

EAU 2017: 4th ESO Prostate Cancer Observatory: The Imaging Specialist’s Perspective on PSMA March 24, 2017

EAU 2017: What is the optimal post-operative management of men with lymph node recurrent prostate cancer after salvage lymph node dissection? Results from a large, multi-institutional series March 24, 2017

Cytoreductive Radical Prostatectomy cRP in men with hormone-naive, metastatic prostate cancer (mPCA) | EAU 2017: March 24, 2017

EAU 2017: Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP) March 24, 2017

EAU 2017: Predictors of early cancer specific and other cause mortality in high risk prostate cancer patients after radical prostatectomy: Results from a large, multi-institutional analysis March 24, 2017

EAU 2017: Does nadir testosterone at the end of long term androgen deprivation therapy predict outcomes in high risk prostate cancer? Data from a phase III trial March 24, 2017

EAU 2017: Extended pelvic lymph node dissection for intermediate-high risk prostate cancer: Frequency and distribution of nodal metastases March 24, 2017

EAU 2017: Freedom from androgen deprivation and radiotherapy therapy after upfront minimally invasive surgery for high-risk prostate cancers March 24, 2017

EAU 2017: Semi-ecologic, nationwide, population-based study of GnRH agonists, orchiectomy and risk of cardiovascular disease March 24, 2017

EAU 2017: 4th ESO Prostate Cancer Observatory: The Urologists Perspective March 24, 2017

EAU 2017: Assessing the 20-year outcomes of radical prostatectomy for high risk prostate cancer: Results from a large, multi-institutional series March 24, 2017

EAU 2017: Improved recurrence-free survival in locally advanced prostate cancer after robot-assisted radical prostatectomy with 3D-cancer mapping constructed by MRI/US fusion biopsy March 24, 2017

EAU 2017: 4th ESO Prostate Cancer Observatory: Innovation and Care in the Next 12 Months March 24, 2017

SUFU 2017: Studies on Frality March 8, 2017

SUFU 2017: Lower Urinary Tract Dysfunction Research Network March 8, 2017

SUFU 2017: Best Practice Policy Statement on Urodynamic Antibiotic Prophylaxis in the Non-Index Patient March 7, 2017

ASCO GU 2017: Best of Journals: Renal Cell Carcinoma – Medical Oncology - Session Highlights February 22, 2017

ASCO GU 2017: Phase II trial of TI-CE high dose chemotherapy (HDCT) with drug monitoring for individual carboplatin dosing in patients with relapsed advanced germ cell tumors: A multicenter prospective GETUG trial. - Session Highlights February 20, 2017

Page 402 of 507